# US 12,180,203 B1 · 2-(benzo[d]thiazol-2-yl)-n′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide as an antimicrobial compound

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 12,180,203 B1
- Document ID: US12180203B1
- Status: Granted
- Kind: B1
- Application number: 18/616,577
- Filed: 2024-03-26
- Granted: 2024-12-31
- Earliest claimed: 2023-10-13
- Assignees: King Faisal University
- Applicants: King Faisal University
- Inventors: Hany Mohamed Abd El-Lateef Ahmed; Mai Mostafa Khalaf Ali; Antar Ahmed Abdelhamid Ahmed; Amer A. Amer
- Web page: https://patentgrep.com/patent/US12180203B1

## CPC

- C07D 417/12: linked by a chain containing hetero atoms as chain links
- A61P 31/04: Antibacterial agents
- A61P 31/10: Antimycotics
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A 2-(benzo[d]thiazol-2-yl)-N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide compound, its synthesis, and its use as an antimicrobial agent.

## Claims

### Claim 1

A method of treating a microbial infection in a patient comprising administering to a patient in need thereof a therapeutically effective amount of a 2-(benzo[d]thiazol-2-yl)-N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide compound.

### Claim 2 (depends on 1)

The method of treating the microbial infection of claim 1, wherein the microbial infection is caused by one or more bacteria or fungi.

### Claim 3 (depends on 2)

The method of treating the microbial infection of claim 2, wherein the microbial infection is caused by one or more gram positive bacteria, one or more gram negative bacteria, one or more fungi, or a combination thereof.

### Claim 4 (depends on 3)

The method of treating the microbial infection of claim 3, wherein the one or more gram positive bacteria are Bacillus cereus, Staphylococcus aureus, or a combination thereof.

### Claim 5 (depends on 3)

The method of treating the microbial infection of claim 3, wherein the one or more gram negative bacteria are Pseudomonas aeruginosa, Escherichia coli, or a combination thereof.

### Claim 6 (depends on 3)

The method of treating the microbial infection of claim 3, wherein the one or more fungi are Aspergillus flavus, Chrysosporium keratinophilum, or a combination thereof.